APA (7th ed.) Citation

Hao, N., Kondo, N., Arai, K., Kudo, N., Murai, T., Fujisawa, J., . . . Kawashima, H. (2026). Five-Year Drug Survival and Discontinuation Reasons for Eight Biological Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: A Retrospective Analysis of 1182 Patients from the Niigata Orthopedic Surgery Rheumatoid Arthritis Database (NOSRAD). Journal of Clinical Medicine, 15(5), 2075. https://doi.org/10.3390/jcm15052075

Chicago Style (17th ed.) Citation

Hao, Nariaki, Naoki Kondo, Katsumitsu Arai, Naoko Kudo, Takehiro Murai, Junichi Fujisawa, Yasufumi Kijima, Rika Kakutani, and Hiroyuki Kawashima. "Five-Year Drug Survival and Discontinuation Reasons for Eight Biological Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: A Retrospective Analysis of 1182 Patients from the Niigata Orthopedic Surgery Rheumatoid Arthritis Database (NOSRAD)." Journal of Clinical Medicine 15, no. 5 (2026): 2075. https://doi.org/10.3390/jcm15052075.

MLA (9th ed.) Citation

Hao, Nariaki, et al. "Five-Year Drug Survival and Discontinuation Reasons for Eight Biological Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis: A Retrospective Analysis of 1182 Patients from the Niigata Orthopedic Surgery Rheumatoid Arthritis Database (NOSRAD)." Journal of Clinical Medicine, vol. 15, no. 5, 2026, p. 2075, https://doi.org/10.3390/jcm15052075.